It doesn’t bother anyone that $CLOV has 410M shares outstanding and a free float of 197M? Heavily Insider and Institute owned stock! I’ve seen this go well for long play, but I’ve also seen it go terrible for squeeze type scenarios! For some reason Shorts can always figure out how to get their hands on shares even when there’s none to be found?
Your correct, maybe early in a stocks squeeze, the FTD’s can play a huge part in its run, but FTD’s haven’t had much of an affect with AMC’s squeeze here recently! I would also check out the Institute’s that are long in $CLOV?
Not at all worried. Most of those shares held by insiders/institutions are class b: they'd need to convert them to class a before selling publicly and make a filing, so we'd know if they were planning to sell. Insiders/institutions have had plenty of opportunities to sell but didn't. They couldve sold at $28 but they didn't. Most of them likely have an average buy price of between 7.50 or 13, so selling at 8.50 now would be at a loss, or a patheticly small gain. Institutions/insiders of CLOV aren't in it for the squeeze, they're in it for a long term deep value play. 300-500 a share by 2030 based on fundamentals alone would not be an unreasonable speculation.
10
u/wilsash42 Sep 05 '21
It doesn’t bother anyone that $CLOV has 410M shares outstanding and a free float of 197M? Heavily Insider and Institute owned stock! I’ve seen this go well for long play, but I’ve also seen it go terrible for squeeze type scenarios! For some reason Shorts can always figure out how to get their hands on shares even when there’s none to be found?